What Sell-Off? Biotechs Cruise: CLVS, SGEN

Stocks in Sharp Sell-Off on Potential FED Rate Increase and Strong Dollar Deflation is Still Lurking S&P Down 1.7%, NASDAQ down 1.67% Biotech stocks avoided the severe sell-off today apparently immune to the strong dollar, flat earnings growth and FED interest rate concerns. Although life science stocks were mixed the bellwether ETFs held their ground: […]

Continue Reading

Biotechs Roaring Back: Do They Sense A Deal? Update -1 ABBV/PCYC

Whoa! $261.25 And the winner is Abbvie (ABBV) for $21B! Pharmacyclics Buzz Is Back  Biotech stocks covered the green screen today, despite a listless general market, driven by deal talk regarding Pharmacyclics (PCYC). Q4 2014 sales of their potential blockbuster drug Imbruvica for chronic lymphocytic leukemia hit $185M and is forecasted to hit the $1B […]

Continue Reading

Mid Cap Emerging Biopharmaceutical Companies: Valuations Do Matter for M&A

Update-1… On Onyx $10.4B Buyout By Amgen (AMGN) Valuation Models for  Biopharma Stocks -M&A Update In October 2013 we compared emerging biotech stocks after the acquisition of Onyx Pharmaceuticals by Amgen (AMGN). Now that rumors are “out there” for the acquisition of Pharmacyclics (PCYC) by large healthcare companies such as Johnson and Johnson (JNJ) and […]

Continue Reading

SierraSnow Blog 2/27-3/3/15…. More Snowpack

More snow coming this weekend: Jet Stream  in Place earth :: an animated map of global wind, weather, and ocean conditions National Maps – NOAA’s National Weather Service 814prcp.new.gif 719×759 pixels Colder wetter bringing 12 in.+ Mammoth Lakes Weather brought to you by Howard Sheckter  

Continue Reading

Rayno Biopharmaceutical Stocks: PCYC Buzz Drive Biotechs Higher… Update-1

2/27 Friday After a big February biotechs turned red today with major ETFs off about 1%. In light of recent M&A talk about Pharmacyclics, Inc. (PCYC) at Market Cap of $16.6B we will look at other top Mid-Cap biopharmaceutical stocks for comparison to our motif below: ALNY, BMRN, INCY, MDVN, PBYI etc. Rayno Mid-Caps Outperform […]

Continue Reading